2,4-Diaminopyrimidine MK2 inhibitors. Part II: Structure-based inhibitor optimization

被引:15
作者
Harris, Christopher M. [1 ]
Ericsson, Anna M. [1 ]
Argiriadi, Maria A. [1 ]
Barberis, Claude [1 ]
Borhani, David W. [1 ]
Burchat, Andrew [1 ]
Calderwood, David J. [1 ]
Cunha, George A. [1 ]
Dixon, Richard W. [1 ]
Frank, Kristine E. [1 ]
Johnson, Eric F. [1 ]
Kamens, Joanne [1 ]
Kwak, Silvia [1 ]
Li, Biqin [1 ]
Mullen, Kelly D. [1 ]
Perron, Denise C. [1 ]
Wang, Lu [1 ]
Wishart, Neil [1 ]
Wu, Xiaoyun [1 ]
Zhang, Xiaolei [1 ]
Zmetra, Tami R. [1 ]
Talanian, Robert V. [1 ]
机构
[1] Abbott Labs, Worcester, MA 01605 USA
关键词
MAPKAP-K2; MK2; TNF alpha; Diaminopyrimidine;
D O I
10.1016/j.bmcl.2009.10.103
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We describe structure-based optimization of a series of novel 2,4-diaminopyrimidine MK2 inhibitors. Co-crystal structures (see accompanying Letter) demonstrated a unique inhibitor binding mode. Resulting inhibitors had IC50 values as low as 19 nM and moderate selectivity against a kinase panel. Compounds 15, 31a, and 31b inhibit TNF alpha production in peripheral human monocytes. (c) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:334 / 337
页数:4
相关论文
共 8 条
[1]   Pyrrolopyridine inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2) [J].
Anderson, David R. ;
Meyers, Marvin J. ;
Vernier, William F. ;
Mahoney, Matthew W. ;
Kurumbail, Ravi G. ;
Caspers, Nicole ;
Poda, Gennadiy I. ;
Schindler, John F. ;
Reitz, David B. ;
Mourey, Robert J. .
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (11) :2647-2654
[2]   2,4-Diaminopyrimidine MK2 inhibitors. Part I: Observation of an unexpected inhibitor binding mode [J].
Argiriadi, Maria A. ;
Ericsson, Anna M. ;
Harris, Christopher M. ;
Banach, David L. ;
Borhani, David W. ;
Calderwood, David J. ;
Demers, Megan D. ;
DiMauro, Jennifer ;
Dixon, Richard W. ;
Hardman, Jennifer ;
Kwak, Silvia ;
Li, Biqin ;
Mankovich, John A. ;
Marcotte, Douglas ;
Mullen, Kelly D. ;
Ni, Baofu ;
Pietras, M. ;
Sadhukhan, Ramkrishna ;
Sousa, Silvino ;
Tomlinson, Medha J. ;
Wang, Lu ;
Xiang, Tao ;
Talanian, Robert V. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (01) :330-333
[3]   Rational mutagenesis to support structure-based drug design: MAPKAP kinase 2 as a case study [J].
Argiriadi, Maria A. ;
Sousa, Silvino ;
Banach, David ;
Marcotte, Douglas ;
Xiang, Tao ;
Tomlinson, Medha J. ;
Demers, Megan ;
Harris, Christopher ;
Kwak, Silvia ;
Hardman, Jennifer ;
Pietras, Margaret ;
Quinn, Lisa ;
DiMauro, Jennifer ;
Ni, Baofu ;
Mankovich, John ;
Borhani, David W. ;
Talanian, Robert V. ;
Sadhukhan, Ramkrishna .
BMC STRUCTURAL BIOLOGY, 2009, 9
[4]   Cytokine inhibitors in the treatment of rheumatoid arthritis [J].
Gabay, C .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2002, 2 (02) :135-149
[5]   Targeting innate immunity protein kinase signalling in inflammation [J].
Gaestel, Matthias ;
Kotlyarov, Alexey ;
Kracht, Michael .
NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (06) :480-499
[6]   A general strategy for creating "Inactive-conformation" Abl inhibitors [J].
Okram, Barun ;
Nagle, Advait ;
Adrian, Francisco J. ;
Lee, Christian ;
Ren, Pingda ;
Wang, Xia ;
Sim, Taebo ;
Xie, Yongping ;
Wang, Xing ;
Xia, Gang ;
Spraggon, Glen ;
Warmuth, Markus ;
Liu, Yi ;
Gray, Nathanael S. .
CHEMISTRY & BIOLOGY, 2006, 13 (07) :779-786
[7]   Pyrrolo-pyrimidones: A novel class of MK2 inhibitors with potent cellular activity [J].
Schlapbach, Achim ;
Feifel, Roland ;
Hawtin, Stuart ;
Heng, Richard ;
Koch, Guido ;
Moebitz, Henrik ;
Revesz, Laszlo ;
Scheufler, Clemens ;
Velcicky, Juraj ;
Waelchli, Rudolf ;
Huppertz, Christine .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (23) :6142-6146
[8]   The discovery of carboline analogs as potent MAPKAP-K2 inhibitors [J].
Wu, Jiang-Ping ;
Wang, Ji ;
Abeywardane, Asitha ;
Andersen, Denise ;
Emmanuel, Michel ;
Gautschi, Elda ;
Goldberg, Daniel R. ;
Kashem, Mohammed A. ;
Lukas, Susan ;
Mao, Wang ;
Martin, Leslie ;
Morwick, Tina ;
Moss, Nell ;
Pargellis, Christopher ;
Patel, Usha R. ;
Patnaude, Lori ;
Peet, Gregory W. ;
Skow, Donna ;
Snow, Roger J. ;
Ward, Yancey ;
Werneburg, Brian ;
White, Andre .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (16) :4664-4669